
Regeneron's Data Grab vs. Blockchain: 5 Reasons Why Patients Win
Regeneron wants your DNA. Let's be blunt. The anticipated $600 million bid for 23andMe’s genetic data isn’t motivated by any spirit of altruism — it’s pure profit. It's about your body becoming a commodity. Here's the good news: you don't have to let it. This isn’t simply an issue of...